Rosos, Joshua G.
HRN: 08-09-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 750MG (VIAL)
05/24/2023
05/31/2023
IVT
750mg
Q8
Acute Pyelonephritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes